Full-Time

Senior Research Associate II

Vivarium Operations, 24121-R-675-PCP

Posted on 7/30/2024

ArsenalBio

ArsenalBio

201-500 employees

Develops programmable cell therapies for cancer

Biotechnology
Healthcare

Compensation Overview

$102k - $125kAnnually

Junior, Mid

San Bruno, CA, USA

Work is onsite based in our South San Francisco office.

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
Communications
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Masters in oncology, immunology, biotechnology or related field with 2+ years of relevant industry or academic experience or Bachelors degree with 4+ years relevant experience
  • Cell culture experience with mammalian cell lines with additional weight given for CAR-T cells
  • Animal health experience in identifying clinical observations and providing treatments
  • Extensive experience in establishing mouse tumor models in immune competent and compromised animals
  • Proficiency in drug administration (SQ, IP, IV, and PO)
  • Proficiency in various blood collection routes (Sub-M and others)
  • Proficiency in rodent full body necropsy
  • Software experience in Excel, Google suite, Prism, Powerpoint, electronic lab notebooks, and in vivo data management platforms
  • Ability to follow instructions and work independently
  • Ability to effectively manage time and prioritize tasks to ensure all assignments are completed on or before deadlines
  • Must have excellent troubleshooting, organization, and planning skills, and the ability to work under timeline in a fast-paced environment
  • Excellent written and oral communication skills
Responsibilities
  • Support the Vivarium Operations and In Vivo Translation teams by conducting animal model studies in oncology to evaluate the activity of programmable cell therapy.
  • Adhere to IACUC guidelines to ensure ethical treatment and welfare of laboratory animals.
  • Maintain and expand cancer and therapeutic cell lines.
  • Execute hands-on responsibilities including, but not limited to animal handling and restraint, administration via various routes, in-life measurements, clinical observations, sample collection and processing, and accurate data collection.
  • Introduce and quantify tumor burden by volumetric measurement bioluminescent imaging.
  • Harvest and analyze in vivo samples by flow cytometry and other in vitro assays.
  • Document, organize, maintain, review, and report experimental records for research and regulatory requirements.

ArsenalBio focuses on developing programmable cell therapies to treat solid tumor cancers. Their approach involves reprogramming cells to enhance their ability to fight cancer. The company is currently in the clinical stage, concentrating on research and development to bring these therapies to market. Their target audience includes patients with solid tumor cancers, a significant segment of cancer patients worldwide. ArsenalBio aims to generate revenue through the commercialization of their therapies once they receive approval. The team consists of experts from various scientific fields and professionals with clinical and manufacturing backgrounds, all working together to create effective cancer treatments.

Company Stage

Series C

Total Funding

$612.8M

Headquarters

San Francisco, California

Founded

2019

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-1%

2 year growth

15%
Simplify Jobs

Simplify's Take

What believers are saying

  • ArsenalBio secured $325 million in Series C funding for therapy development.
  • The first patient was dosed in a Phase 1/2 trial for renal cell carcinoma.
  • Collaboration with Genentech enhances T-cell therapy research and development.

What critics are saying

  • Competition from CRISPR Therapeutics and Editas Medicine in cancer treatment.
  • High development costs may limit ArsenalBio's ability to scale therapies.
  • Regulatory hurdles could delay market entry and affect revenue generation.

What makes ArsenalBio unique

  • ArsenalBio uses CRISPR-based genome engineering for precise cell therapy development.
  • The company integrates machine learning to enhance immune cell therapy efficacy.
  • ArsenalBio's CITE technology targets tumor microenvironments, improving therapy effectiveness.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision coverage

Virtual & telehealth options

Parental leave

Flexible work schedule

Flexible PTO

Mental health resources

INACTIVE